AdventHealth Orlando is a 1705-bed, faith-based, non-profit, tertiary, research and academic medical center located in Orlando, Florida, servicing Central Florida and the Orange county region. AdventHealth Orlando is the region's largest academic university-level teaching center.

There are 1,705 beds in AdventHealth Orlando - Investigational Drug Services.

During the past decade, AdventHealth Orlando - Investigational Drug Services conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AdventHealth Orlando - Investigational Drug Services" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "AdventHealth Orlando - Investigational Drug Services" are "Advanced Solid Tumors" (1 trials), "Atopic Dermatitis" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Dermatitis, Atopic" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "AdventHealth Orlando - Investigational Drug Services" in a lesser frequency.

Most popular intervention types in "AdventHealth Orlando - Investigational Drug Services" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (2 trials), "Encorafenib" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Orlando - Investigational Drug Services" are 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "AdventHealth Orlando - Investigational Drug Services". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in AdventHealth Orlando - Investigational Drug Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Orlando - Investigational Drug Services, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".